Technology Partners
- Washington University
- The U.S. Public Health Service
- The Rockefeller University
- Toray Industries, Inc.
- Southern Research Institute
- Monogram Biosciences
- The Scripps Institute
- The Capital Region of Denmark
- Rush University Medical Center
- Nationwide Children's Hospital
- Promega Corporation
- Prolume, LTD
- Diagnostic Hybrids, Inc.
- Boston University
- Tecnologias para la Vida
Apath,L.L.C
1173A Second Avenue
Suite 355
New York, NY 10065
(347) 533-4831
April 25, 2012
Apath expands HCV contract screening sublicense with Southern Research Institute by expanding the current sublicense to include full virus screening systems.
January 1, 2010
Apath expands HCV technology portfolio by acquiring licensing rights to three new HCV technologies developed at The Rockefeller University.
August 1, 2009
Apath expands HCV technology portfolio by acquiring licensing rights to new HCV technologies developed by Dr. Jens Bukh and his colleagues at The University Copenhagen.
- HCV Replicon Technologies
- HCVcc Full Virus Life Cycle Technologies
- Highly Permissive Cell Line Technologies
- HCV Research and Development Tools
Please contact us for additional information on a sublicensing opportunity for HCV-related intellectual property.
Our development strategies for clients involve providing them access to innovative anti-HCV development platforms and exceptional research and development tools. Below are links to five white papers describing some of our most requested research tools by our global licensees.
Our development solutions for clients encompass a harmonized approach of providing sublicensing opportunities to our extensive patent portfolio, assistance in implementing our anti-HCV technologies and access to our experienced virologists.
